TABLE 11.
Comparison of 18F‐FDG absorbed dose (mGy/MBq.h) of UF and IT'IS phantoms with ICRP data
| 5‐year‐old | 11‐year‐old | 14‐year‐old | ||||||
|---|---|---|---|---|---|---|---|---|
| IT'IS | ICRP | IT'IS | UF | ICRP (10 years) | IT'IS | UF | ICRP (15 years) | |
| Gonads | 8.46E‐2 | 4.30E‐2 | 2.87E‐2 | 3.27E‐2 | 2.70E‐2 | 1.56E‐2 | 2.40E‐2 | 1.80E‐2 |
| Skin | 1.13E‐2 | 2.60E‐2 | 1.40E‐2 | 8.82E‐03 | 1.50E‐2 | 4.72E‐3 | 6.93E‐3 | 9.60E‐3 |
| Stomach | 4.94E‐2 | 3.50E‐2 | 2.05E‐2 | 3.59E‐2 | 2.20E‐2 | 1.83E‐2 | 2.45E‐2 | 1.40E‐2 |
| Brain | 4.55E‐2 | 4.60E‐2 | 3.99E‐2 | 3.75E‐2 | 4.10E‐2 | 3.34E‐2 | 3.71E‐2 | 3.90E‐2 |
| Gall bladder | 2.98E‐2 | 2.90E‐2 | 2.41E‐2 | 3.74E‐2 | 1.80E‐2 | 2.07E‐2 | 2.84E‐2 | 1.10E‐2 |
| Heart | 3.12E‐1 | 2.10E‐1 | 1.25E‐1 | 1.20E‐1 | 1.30E‐1 | 5.42E‐2 | 8.64E‐2 | 8.70E‐2 |
| Liver | 6.78E‐2 | 6.30E‐2 | 3.96E‐2 | 4.19E‐2 | 4.20E‐2 | 2.94E‐2 | 2.80E‐2 | 2.80E‐2 |
| Bladder | 1.39E0 | 3.40E‐1 | 1.10E0 | 1.44E‐2 | 2.50E‐1 | 2.55E‐1 | 5.44E‐2 | 1.60E‐1 |
| Small intestine | 5.28E‐2 | 4.00E‐2 | 2.85E‐2 | 3.19E‐2 | 2.50E‐2 | 1.97E‐2 | 2.76E‐2 | 1.60E‐2 |
| Esophagus | 4.29E‐2 | 3.50E‐2 | 2.86E‐2 | 3.71E‐2 | 2.20E‐2 | 2.09E‐2 | 2.81E‐2 | 1.50E‐2 |
| Pancreas | 5.29E‐2 | 4.00E‐2 | 2.17E‐2 | 0.03735 | 2.60E‐2 | 2.00E‐2 | 2.75E‐2 | 1.60E‐2 |
| Thymus | 5.46E‐2 | 3.50E‐2 | 2.67E‐2 | 3.59E‐2 | 2.20E‐2 | 1.96E‐2 | 2.89E‐2 | 1.50E‐2 |
| Kidneys | 4.85E‐2 | 4.50E‐2 | 1.90E‐2 | 3.41E‐2 | 2.90E‐2 | 1.88E‐2 | 2.70E‐2 | 2.10E‐2 |
| Colon | 4.96E‐2 | 3.90E‐2 | 2.65E‐2 | 3.70E‐2 | 2.50E‐2 | 2.19E‐2 | 2.68E‐2 | 1.60E‐2 |
| Lungs | 5.99E‐2 | 6.20E‐2 | 3.54E‐2 | 3.39E‐2 | 4.10E‐2 | 2.74E‐2 | 2.39E‐2 | 2.90E‐2 |
| Red bone marrow | 3.93E‐2 | 3.20E‐2 | 1.71E‐2 | 2.57E‐2 | 2.10E‐2 | 1.30E‐2 | 2.07E‐2 | 1.40E‐2 |
| Effective dose (mSv/MBq) | 9.96E‐2 | 5.60E‐2 | 6.60E‐2 | 3.58E‐2 | 3.70E‐2 | 2.66E‐2 | 3.34E‐2 | 2.40E‐2 |